{"transactions":[{"id":803237,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-22T21:00:04.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One fourth of the options vest on April 20, 2027 and an additional 1/36th of the remaining options vest on each monthly anniversary thereafter in substantially equal increments."}],"balance_after":20000,"derivative":{"exercise_price":7.3,"expiration_date":"2036-04-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-170730","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526170730/ownership.xml","form_type":"4"}},{"id":803236,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-22T21:00:04.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. One third of the RSUs awarded vest on July 1, 2027, and the remainder of the RSUs vest ratably over the next eight quarters in substantially equal increments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. One third of the RSUs awarded vest on July 1, 2027, and the remainder of the RSUs vest ratably over the next eight quarters in substantially equal increments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. One third of the RSUs awarded vest on July 1, 2027, and the remainder of the RSUs vest ratably over the next eight quarters in substantially equal increments."}],"balance_after":20000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-170730","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526170730/ownership.xml","form_type":"4"}},{"id":819096,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-02T20:46:14.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":929,"price":1.95,"value":1811.55,"ownership":{"direct":true},"balance_after":31741,"source":{"system":"sec-edgar","filing":"0001372514-26-000032","document":"wk-form4_1775162772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000032/wk-form4_1775162772.xml","form_type":"4"}},{"id":850467,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-10T20:37:12.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":13067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2027, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":13067,"derivative":{"exercise_price":1.98,"exercise_date":"2027-04-01","expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":13067},"source":{"system":"sec-edgar","filing":"0001372514-26-000014","document":"wk-form4_1773175029.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000014/wk-form4_1773175029.xml","form_type":"4"}},{"id":850466,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-10T20:37:12.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":6533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2027, April 1, 2028 and April 1, 2029, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":32670,"source":{"system":"sec-edgar","filing":"0001372514-26-000014","document":"wk-form4_1773175029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000014/wk-form4_1773175029.xml","form_type":"4"}},{"id":855588,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-06T19:03:53.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":238,"price":2.02,"value":480.76,"ownership":{"direct":true},"balance_after":26137,"source":{"system":"sec-edgar","filing":"0001372514-26-000007","document":"wk-form4_1772823830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000007/wk-form4_1772823830.xml","form_type":"4"}},{"id":1182817,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T00:28:59.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":15543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2026, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":15543,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":15543},"source":{"system":"sec-edgar","filing":"0001372514-25-000035","document":"wk-form4_1743640133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000035/wk-form4_1743640133.xml","form_type":"4"}},{"id":1182816,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-04-03T00:28:59.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":7772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":26375,"source":{"system":"sec-edgar","filing":"0001372514-25-000035","document":"wk-form4_1743640133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000035/wk-form4_1743640133.xml","form_type":"4"}},{"id":1459511,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T19:16:20.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":14710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 1, 2025, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":14710,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":14710},"source":{"system":"sec-edgar","filing":"0001372514-24-000094","document":"wk-form4_1720034173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000094/wk-form4_1720034173.xml","form_type":"4"}},{"id":1459510,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-07-03T19:16:20.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":7355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of July 1, 2025, July 1, 2026 and July 1, 2027, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":18577,"source":{"system":"sec-edgar","filing":"0001372514-24-000094","document":"wk-form4_1720034173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000094/wk-form4_1720034173.xml","form_type":"4"}},{"id":1478640,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-06-14T19:40:23.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":1431,"price":5.29,"value":7569.99,"ownership":{"direct":true},"balance_after":11222,"source":{"system":"sec-edgar","filing":"0001372514-24-000063","document":"wk-form4_1718394015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000063/wk-form4_1718394015.xml","form_type":"4"}},{"id":1766716,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T20:48:16.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0.5677,"exercise_date":"2023-09-29","expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001372514-23-000149","document":"wk-form4_1696366080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000149/wk-form4_1696366080.xml","form_type":"4"}},{"id":1766715,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-10-03T20:48:16.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":88338,"source":{"system":"sec-edgar","filing":"0001372514-23-000149","document":"wk-form4_1696366080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000149/wk-form4_1696366080.xml","form_type":"4"}},{"id":1965229,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T01:14:50.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":10400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":10400,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":10400},"source":{"system":"sec-edgar","filing":"0001372514-23-000034","document":"wf-form4_167823807843002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000034/wf-form4_167823807843002.xml","form_type":"4"}},{"id":1965228,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-03-08T01:14:50.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":15600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":25838,"source":{"system":"sec-edgar","filing":"0001372514-23-000034","document":"wf-form4_167823807843002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000034/wf-form4_167823807843002.xml","form_type":"4"}},{"id":2132227,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-25T21:34:17.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on October 21, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":6.78,"expiration_date":"2032-10-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-111246","document":"tm2228925-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922111246/tm2228925-3_4seq1.xml","form_type":"4"}},{"id":2132226,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-10-25T21:34:17.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of October 21, 2023, October 21, 2024 and October 21, 2025, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":10238,"source":{"system":"sec-edgar","filing":"0001104659-22-111246","document":"tm2228925-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922111246/tm2228925-3_4seq1.xml","form_type":"4"}},{"id":2413137,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-04T00:03:48.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":25000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-22-011493","document":"tm225348d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922011493/tm225348d4_4.xml","form_type":"4"}},{"id":2500254,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-11-22T21:31:09.000Z","date":"2021-10-21","kind":"grant","acquired":true,"shares":9520,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were omitted from the Reporting Person's Form 4 filed on November 10, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received by the Reporting Person in connection with the acquisition by the issuer of all of the outstanding securities of Bayon Therapeutics, Inc. on October 21, 2021."}],"balance_after":9520,"source":{"system":"sec-edgar","filing":"0001104659-21-142530","document":"tm2133588-2_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921142530/tm2133588-2_4a.xml","form_type":"4/A","original_submission_date":"2021-11-10"}},{"id":2517477,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-10T21:17:24.000Z","date":"2021-10-21","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on October 21, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":50000,"derivative":{"exercise_price":1.99,"expiration_date":"2031-10-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-21-136953","document":"tm2132572-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921136953/tm2132572-1_4seq1.xml","form_type":"4"}}]}